bioRxiv Science⌕ Search

Biology subjects

Nagamani, S.

Publications and source records attributed to Nagamani, S..

2 recordsLinked to original sources

OMNI: Optimized Multi-view Network Integration with Heterogeneous Graph Attention for Biomedical Interaction Prediction

MotivationAccurate prediction of biomedical relationships, such as chemical-gene interactions, is fundamental to understanding disease mechanisms and advancing drug discovery. With the rapid growth of heterogeneous biological data, modeling large-scale, multi-entity networks has become increasingly challenging. Traditional approaches, including homogeneous GNNs (e.g., GCN, GAT) and meta-path-based random walks, struggle to efficiently capture high-order, diverse neighborhood information in complex biomedical graphs. To address these limitations, we propose a novel multi-view heterogeneous graph attention network (GAT)-based architecture that effectively aggregates rich, heterogeneous interactions across multiple biomedical entity types. The proposed encoder captures comprehensive structural and semantic information while remaining computationally efficient. Through optimized aggregation strategies and multi-processing, the model generates high-quality node embeddings with significantly reduced training time. For relation prediction, multiple decoder architectures were evaluated, with a multilayer perceptron (MLP) identified as the most effective for accurate multi-type relation classification. The resulting network comprises 124,604 unique nodes and 48,482,286 interactions. ResultsExperimental results show that the proposed model consistently outperforms state-of-the-art methods, including CGINet, Node2Vec, and the GCN-based BioNet, achieving an AUROC of 0.91 for chemical-gene interaction prediction. The model further explores its ability to identify top-ranking chemical-gene interactions in cancer and to predict gene-phytochemical relationships. Overall, this work introduces a scalable and powerful framework for biomedical relation prediction, with strong potential applications in drug screening and disease mechanism discovery. Key PointsO_LIWe constructed a large-scale heterogeneous biological interaction network by integrating curated datasets across multiple entity types, including chemicals, genes, pathways, and diseases. C_LIO_LIWe propose a novel graph neural network framework, Optimized Multi-View Network Integration (OMNI), based on an encoder-decoder architecture, which employs a multi-view heterogeneous Graph Attention Network (GAT) to learn entity embeddings from subgraphs and a multilayer perceptron (MLP) decoder to predict chemical-gene interactions (CGIs). C_LIO_LIWe integrated a PyTorch Lightning based parallel training strategy to scale up the learning process, significantly enhancing the models ability to efficiently handle large-scale heterogeneous data. C_LIO_LIWe demonstrated the applicability of OMI by evaluating cancer-related chemical-gene interactions and vitamin D receptor (VDR)-phytochemical interactions, including the prediction of interaction types. C_LI

bioinformatics↗

Molecular Property Diagnostic Suite for COVID-19 (MPDSCOVID-19): An open access disease specific drug discovery portal

Computational drug discovery is intrinsically interdisciplinary and has to deal with the multifarious factors which are often dependent on the type of disease. Molecular Property Diagnostic Suite (MPDS) is a Galaxy based web portal which was conceived and developed as a disease specific web portal, originally developed for tuberculosis (MPDSTB). As specific computational tools are often required for a given disease, developing a disease specific web portal is highly desirable. This paper emphasises on the development of the customised web portal for COVID-19 infection and is referred to as MPDSCOVID-19. Expectedly, the MPDS suites of programs have modules which are essentially independent of a given disease, whereas some modules are specific to a particular disease. In the MPDSCOVID-19 portal, there are modules which are specific to COVID-19, and these are clubbed in SARS-COV-2 disease library. Further, the new additions and/or significant improvements were made to the disease independent modules, besides the addition of tools from galaxy toolshed. This manuscript provides a latest update on the disease independent modules of MPDS after almost 6 years, as well as provide the contemporary information and tool-shed necessary to engage in the drug discovery research of COVID-19. The disease independent modules include file format converter and descriptor calculation under the data processing module; QSAR, pharmacophore, scaffold analysis, active site analysis, docking, screening, drug repurposing tool, virtual screening, visualisation, sequence alignment, phylogenetic analysis under the data analysis module; and various machine learning packages, algorithms and in-house developed machine learning antiviral prediction model are available. The MPDS suite of programs are expected to bring a paradigm shift in computational drug discovery, especially in the academic community, guided through a transparent and open innovation approach. The MPDSCOVID-19 can be accessed at http://mpds.neist.res.in:8085.

bioinformatics↗